“…DEEM was used to obtain Rimazolium (3), which is a registered analgesic drug, as well as an analog (4) of Rimazolium, an antagonist of prostaglandines more potent than Phenylbutazone. DEEM was also applied to synthesize compounds with anti-inflammatory (5) or calming and *Address correspondence to this author at the Department of Synthesis and Chemical Technology of Pharmaceutical Substances, Faculty of Pharmacy, Medical University of Lublin, 6 Staszica Str., PL-20081 Lublin, Poland; Tel: +48-81-5324083; Fax: +48-81-5322910: E-mail: agnieszka.kaczor@am.lublin.pl antidepressive (via GABA receptor) activity (6). EMCA was a reagent to produce imidazo[1,2-a]pyrimidines with potential affinity towards opioid and serotonin receptors (7a, 7b) (Fig.…”